5736
E. Zieminska et al. / Bioorg. Med. Chem. Lett. 18 (2008) 5734–5737
ortho- to the ether linkage (2a) leads to diminished activity while
introduction of an additional bromine ortho- to the catechol (4)
has the opposite result. Clearly further studies are needed to deci-
pher the effect of aryl substitution pattern.
In conclusion, our results confirm that the calcium-mobilizing
potential of bastadins critically depends on the presence and
location of aryl substituents and indicate that constraining of the
diarylether moiety in a macrocycle is not a prerequisite for activity.
Thus, a major simplification of the structure of bastadins, resulting
in open-chain analogs that conserve the bromocatechol ether
moiety, is possible without obligatory lose of their ability to release
calcium via ryanodine receptors. Some of these compounds, in
particular the one embodying the dibromocatechol ether moiety
found in bastadin 5, retain this activity. This major structural
simplification facilitates the development of novel chemical probes
for the study of RyR channels and at the same time compels further
investigations to illuminate the modulating effect that ‘satellite’
substituents (i.e., local and nature of further aromatic ring
substitution, aliphatic chain length, and substitution pattern)
may exert.
Figure 4. Effects of bastadin 5 and analogues 2a, 2b, and 4 (all compounds 20 lM)
on 45Ca2+ uptake in cultured cerebellar granule cells. Accumulation of 45Ca2+ was
measured after 10 min incubation with the compounds and results (means SD,
n = 6) are presented as percent of control. All results were significantly different
from the control (P < 0.05) as verified with ANOVA test.
Acknowledgments
calcium concentration, that is, the effect of 4 > 2b > 2a, the latter
being very slight.
This study was supported by the Poland-Greece Joint Research
and Technology Program 2005–2007 16189-158e. Prof. A. Giannis
is gratefully acknowledged for his assistance in obtaining HRMS
spectra for the compounds tested.
The fact that the influx of 45Ca2+ to neurons evoked by applica-
tion of bastadin 5 and some of the synthetic analogues correlates
with increases in the intracellular calcium levels could be an
indication that they directly activate the receptor-operated or volt-
age-sensitive calcium channels in neuronal plasma membranes.
However, similarly to our previous studies on bastadins (including
bastadin 5),8 increases in the intracellular calcium levels induced
by the most potent analog 4 were found to be sensitive to high con-
centrations of ryanodine and FK506 (Fig. 3).13 This observation
clearly indicates that ryanodine receptors are the primary targets
for their pharmacological activity. Thus, the influx of extracellular
calcium to bastadin-treated neurons appears to be a secondary
effect resulting from the release of calcium from the ryanodine-
sensitive pool. This release leads, in turn, to stimulation of gluta-
mate release from the glutamatergic cerebellar granule neurons
or otherwise leads to secondary activation of the NMDA receptors,
as it has been recently described for PCB 95.14 Therefore both bast-
adin-induced phenomena, an increase in FLUO-3 fluorescence and
activation of 45Ca2+ uptake, represent different aspects of the same
primary biological phenomenon: the release of calcium via ryano-
dine receptors in neurons.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. Clapham, D. E. Cell 1995, 80, 259.
2. (a) Zucchi, R.; Ronca-Testoni, S. Pharmacol. Rev. 1997, 49, 1; (b) Berchtold, M.
W.; Brinkmeier, H.; Müntener, M. Physiol. Rev. 2000, 80, 1215.
3. Mattson, M. P. Aging Cell 2007, 6, 337.
4. Peng, J.; Li, J.; Hamann, M. The Alkaloids: Chemistry and Biology 2005, 61, 59.
5. (a) Mack, M. M.; Molinski, T. F.; Buck, E. D.; Pessah, I. N. J. Biol. Chem. 1994, 269,
23236; (b) Franklin, M. A.; Penn, S. G.; Lebrilla, C. B.; Lam, T. H.; Pessah, I. N.;
Molinski, T. F. J. Nat. Prod. 1996, 59, 1121; (c) DiJulio, D. H.; Watson, E. L.;
Pessah, I. N.; Jacobson, K. L.; Ott, S. M.; Buck, E. D.; Singh, J. C. J. Biol. Chem. 1997,
272, 15687; (d) Pessah, I. N.; Molinski, T. F.; Meloy, T. D.; Wong, P.; Buck, E. D.;
Allen, P. D.; Mohr, F. C.; Mack, M. M. Am. J. Physiol. 1997, 272, C601; (e) Chen, L.;
Molinski, T. F.; Pessah, I. N. J. Biol. Chem. 1999, 274, 32603; (f) González, A.;
Kirsch, W. G.; Shirokova, N.; Pizarro, G.; Brum, G.; Pessah, I. N.; Stern, M. D.;
Cheng, H.; Rios, E. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4380.
6. (a) Couladouros, E. A.; Moutsos, V. I. Tetrahedron Lett. 1999, 40, 7023; (b)
Couladouros, E. A.; Moutsos, V. I. Tetrahedron Lett. 1999, 40, 7027; (c)
Couladouros, E. A.; Moutsos, V. I.; Pitsinos, E. N. ARKIVOC 2003, 15, 92; (d)
Couladouros, E. A.; Pitsinos, E. N.; Moutsos, V. I.; Sarakinos, G. Chem. Eur. J.
2005, 11, 406.
7. Masuno, M. N.; Pessah, I. N.; Olmstead, M. M.; Molinski, T. F. J. Med. Chem. 2006,
49, 4497.
8. Zieminska, E.; Stafiej, A.; Pitsinos, E. N.; Couladouros, E. A.; Moutsos, V.;
Kozlowska, H.; Toczylowska, B.; Lazarewicz, J. W. Neurosignals 2006–2007, 15,
283.
Our newly prepared acyclic analogues embody segments of dif-
ferent naturally occurring bastadins: compound 2a embodies the
‘western’ part of bastadin 16 while compound 2b embodies the
corresponding segment of bastadins 9, 13 and 21; compound 4
embodies the ‘eastern’ part of bastadins 4, 5, 6, 8, 9, 11, 13,16, 17
and 19. It should be noted, however, that recent structure–activity
relationship (SAR) studies by Molinski et al. indicated that the
ketoximino groups present in the natural products are not required
for activity and thus the difference between ‘western’ and ‘eastern’
parts becomes less profound.7 Furthermore, the same studies
strongly support the importance of the shape and size of the mac-
rocyclic half-bastadins. Interestingly, our findings clearly indicate
that constraining the C–O–C–C torsional angle by incorporating
the diarylether in a macrocycle is not a prerequisite for activity.
Thus, the catechol aryl ether substitution pattern potentially plays
the decisive role regarding calcium mobilization activity. The avail-
able data would seem to indicate that a para-substituted catechol
ortho-brominated-para-substituted aryl ether, like the one found
in 2b, is required. This pattern is maintained in compounds 2a
and 4. Intriguingly, introduction of an extra bromine substituent
9. Compound 2a: 38% yield from 1; 1H NMR (500 MHz, CDCl3) d 7.76 (d, J 7.2 Hz,
2H), 7.59 (d, J 7.2 Hz, 2 H), 7.46–7.51 (m, 2H), 7.44–7.37 (m, 6H), 7.01 (d, J
8.2 Hz, 1H), 6.84 (d, J 7.9 Hz, 1H), 6.65–6.71 (br m, 1H), 6.24 (s, 1H), 5.97–6.04
(br m, 1H), 5.5–5.8 (br s, 1H), 3.65–3.69 (m, 2H), 3.57–3.61 (m, 2H), 2.89–2.92
(m, 2H), 2.76–2.79 (m, 2H); HRMS (ESI): m/z: 661.01161 [M+Na+],
C30H26Br2N2O4Na requires 661.01366.Compound 2b: 38% yield from 1; 1H
NMR (500 MHz, CDCl3) d 7.73 (d, J 7.4 Hz, 2H), 7.63 (d, J 7.4 Hz, 2H), 7.39–7.55
(m, 7H), 7.05 (d, J 8.1 Hz, 1H), 7.00 (d, J 8.2 Hz, 1H), 6.89–6.91 (m, 2H), 6.57 (s,
1H), 6.34–6.40 (br m, 1H), 6.03–6.10 (br m, 1H), 5.4–5.8 (br s, 1H), 3.66–3.70
(m, 2H), 3.59–3.63 (m, 2H), 2.88–2.91 (m, 2H), 2.78–2.81 (m, 2H); HRMS (ESI):
m/z: 581.10407 [M+Na+], C30H27BrN2O4Na requires 581.10519.Compound 4: 1H
NMR (500 MHz, acetone-d6): d 11.29 (br s, 1H), 10.89 (br s, 1H), 8,77 (br s, 1H),
7.67 (br s, 2H), 7.55 (br m, 1H), 7.31 (br m, 1H), 7.17 (br s, 1H), 6.40 (br s, 1H),
3.98 (br s, 2H), 3.69 (br s, 2H), 3.29 (br m, 2H), 3.21 (br m, 2H), 1.20–1.56 (m,
4H), 0.90 (br m, 6H); HRMS (ESI): m/z: 756.96752 [M+Na+], C26H31Br3N4O6Na
requires 756.96710.